Literature DB >> 28192036

Using Acute Performance on a Comprehensive Neurocognitive, Vestibular, and Ocular Motor Assessment Battery to Predict Recovery Duration After Sport-Related Concussions.

Alicia M Sufrinko1, Gregory F Marchetti2, Paul E Cohen1, R J Elbin3, Valentina Re4, Anthony P Kontos1.   

Abstract

BACKGROUND: A sport-related concussion (SRC) is a heterogeneous injury that requires a multifaceted and comprehensive approach for diagnosis and management, including symptom reports, vestibular/ocular motor assessments, and neurocognitive testing.
PURPOSE: To determine which acute (eg, within 7 days) vestibular, ocular motor, neurocognitive, and symptom impairments predict the duration of recovery after an SRC. STUDY
DESIGN: Cohort study (prognosis); Level of evidence, 2.
METHODS: Sixty-nine patients with a mean age of 15.3 ± 1.9 years completed a neurocognitive, vestibular/ocular motor, and symptom assessment within 7 days of a diagnosed concussion. Patients were grouped by recovery time: ≤14 days (n = 27, 39.1%), 15-29 days (n = 25, 36.2%), and 30-90 days (n = 17, 24.6%). Multinomial regression was used to identify the best subset of predictors associated with prolonged recovery relative to ≤14 days.
RESULTS: Acute visual motor speed and cognitive-migraine-fatigue symptoms were associated with an increased likelihood of recovery times of 30-90 days and 15-29 days relative to a recovery time of ≤14 days. A model with visual motor speed and cognitive-migraine-fatigue symptoms within the first 7 days of an SRC was 87% accurate at identifying patients with a recovery time of 30-90 days.
CONCLUSION: The current study identified cognitive-migraine-fatigue symptoms and visual motor speed as the most robust predictors of protracted recovery after an SRC according to the Post-concussion Symptom Scale, Immediate Post-concussion Assessment and Cognitive Testing, and Vestibular/Ocular Motor Screening (VOMS). While VOMS components were sensitive in identifying a concussion, they were not robust predictors for recovery. Clinicians may consider particular patterns of performance on clinical measures when providing treatment recommendations and discussing anticipated recovery with patients.

Entities:  

Keywords:  concussion; neurocognitive; ocular motor; recovery; vestibular

Mesh:

Year:  2017        PMID: 28192036     DOI: 10.1177/0363546516685061

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  16 in total

1.  Vergence Endurance Test: A Pilot Study for a Concussion Biomarker.

Authors:  Chang Yaramothu; Lynn D Greenspan; Mitchell Scheiman; Tara L Alvarez
Journal:  J Neurotrauma       Date:  2019-03-28       Impact factor: 5.269

2.  Vestibular and Ocular/Oculomotor Assessment Strategies and Outcomes Following Sports-Related Concussion: A Scoping Review.

Authors:  Carolina P Quintana; Tamara C Valovich McLeod; Anne D Olson; Nicholas R Heebner; Matthew C Hoch
Journal:  Sports Med       Date:  2021-01-05       Impact factor: 11.136

3.  Quantifying the Value of Multidimensional Assessment Models for Acute Concussion: An Analysis of Data from the NCAA-DoD Care Consortium.

Authors:  Gian-Gabriel P Garcia; Steven P Broglio; Mariel S Lavieri; Michael McCrea; Thomas McAllister
Journal:  Sports Med       Date:  2018-07       Impact factor: 11.136

4.  Motion Sickness Susceptibility and Baseline Vestibular and Ocular-Motor Performance in Adolescent Athletes.

Authors:  R J Elbin; Anthony P Kontos; Alicia Sufrinko; Mallory McElroy; Katie Stephenson-Brown; Samantha Mohler; Nathan R D'Amico; Michael W Collins
Journal:  J Athl Train       Date:  2019-08-27       Impact factor: 2.860

5.  Neurosensory Deficits Vary as a Function of Point of Care in Pediatric Mild Traumatic Brain Injury.

Authors:  Andrew R Mayer; Christopher Wertz; Sephira G Ryman; Eileen P Storey; Grace Park; John Phillips; Andrew B Dodd; Scott Oglesbee; Richard Campbell; Ronald A Yeo; Benjamin Wasserott; Nicholas A Shaff; John J Leddy; Rebekah Mannix; Kristy B Arbogast; Timothy B Meier; Matthew F Grady; Christina L Master
Journal:  J Neurotrauma       Date:  2018-03-20       Impact factor: 5.269

6.  Persistent vestibular-ocular impairment following concussion in adolescents.

Authors:  Aaron M Sinnott; R J Elbin; Michael W Collins; Valerie L Reeves; Cyndi L Holland; Anthony P Kontos
Journal:  J Sci Med Sport       Date:  2019-08-08       Impact factor: 4.319

7.  KNOWLEDGE OF VESTIBULAR OCULAR DYSFUNCTION AND UTILIZATION OF VESTIBULAR OCULAR MOTOR SCREENING (VOMS) TOOL COMPONENTS AMONG PROFESSIONAL SPORTS LEAGUE ATHLETIC TRAINERS.

Authors:  Rebecca A Bliss; W David Carr
Journal:  Int J Sports Phys Ther       Date:  2020-08

8.  Neurosensory Screening and Symptom Provocation in Pediatric Mild Traumatic Brain Injury.

Authors:  Andrew R Mayer; Christopher J Wertz; Cidney R Robertson-Benta; Sharvani Pabbathi Reddy; David D Stephenson; Andrew B Dodd; Scott J Oglesbee; Edward J Bedrick; Christina L Master; Mathew Grady; Nicholas A Shaff; Faith M Hanlon; Richard A Campbell; John P Phillips; Roger L Zemek; Keith Owen Yeates; Timothy B Meier; Rebekah Mannix; John J Leddy; Kristy B Arbogast; Grace Park
Journal:  J Head Trauma Rehabil       Date:  2020 Jul/Aug       Impact factor: 3.117

9.  White Matter Abnormalities Associated With Prolonged Recovery in Adolescents Following Concussion.

Authors:  João Paulo Lima Santos; Anthony P Kontos; Sarrah Mailliard; Shawn R Eagle; Cynthia L Holland; Stephen J Suss; Halimah Abdul-Waalee; Richelle S Stiffler; Hannah B Bitzer; Nicholas A Blaney; Adam T Colorito; Christopher G Santucci; Allison Brown; Tae Kim; Satish Iyengar; Alexander Skeba; Rasim S Diler; Cecile D Ladouceur; Mary L Phillips; David Brent; Michael W Collins; Amelia Versace
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

Review 10.  Using concurrent gait and cognitive assessments to identify impairments after concussion: a narrative review.

Authors:  David R Howell; Michael W Kirkwood; Aaron Provance; Grant L Iverson; William P Meehan
Journal:  Concussion       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.